Literature DB >> 23242471

Circulating levels of lipocalin-2 and retinol-binding protein-4 are increased in psoriatic patients and correlated with baseline PASI.

Jorge Romaní1, Assumpta Caixàs, Victoria Ceperuelo-Mallafré, José Manuel Carrascosa, Miquel Ribera, Mercedes Rigla, Joan Vendrell, Jesús Luelmo.   

Abstract

Psoriasis has been related to metabolic syndrome (MS). Adipocytokines produced by white adipose tissue may be involved in the pathogenesis of psoriasis and its association with MS. Our objectives were to characterize the profile of a number of different inflammatory and atherogenic markers, vitamins, adipokines and cytokines and their potential involvement in MS in patients with moderate-to-severe psoriasis without joint involvement compared to anthropometrically matched controls, and to evaluate correlation with severity of the skin disease and changes after narrow-band UVB (NB-UVB) phototherapy. We designed a prospective cross-sectional study. Baseline waist circumference, body fat composition, lipid, carbohydrate and calcium metabolism profile, inflammation markers, homocysteine and vitamins D, B6, B12 and folic acid, leptin, resistin, omentin, lipocalin-2, adipocyte fatty acid-binding protein, retinol-binding protein-4 (RBP-4), interleukin-6, soluble tumour necrosis factor receptor 1 (sTNFR1) and interleukin-17 of 50 psoriasis patients and 50 gender, age and body mass index-matched controls were recorded, then evaluated after NB-UVB in the patients. The patients had higher baseline serum concentrations of leptin, RBP-4, lipocalin-2 and sTNFR1. Baseline psoriasis area and severity index correlated with serum concentrations of RBP-4 and lipocalin-2 only. Principal components analysis disclosed a component including vitamins B12, B6, folic acid, calcidiol and HDL-cholesterol that was only present in healthy controls and opposed to a cluster of variables which promote MS. This component was absent in the patients. Our results point to lipocalin-2 and RBP-4 as relevant mediators of the trend towards MS in psoriatic patients.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23242471     DOI: 10.1007/s00403-012-1306-5

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  16 in total

Review 1.  Does treatment of psoriasis reduce the risk of cardiovascular disease?

Authors:  Sarah Churton; Liza Brown; Thuzar M Shin; Neil J Korman
Journal:  Drugs       Date:  2014-02       Impact factor: 9.546

2.  Increased serum resistin levels correlate with psoriasis: a meta-analysis.

Authors:  Huiyun Huang; Erdong Shen; Shiqing Tang; Xingyou Tan; Xiuli Guo; Qiang Wang; Hongwei Ding
Journal:  Lipids Health Dis       Date:  2015-05-16       Impact factor: 3.876

3.  Anti-TNF-α Drugs Differently Affect the TNFα-sTNFR System and Monocyte Subsets in Patients with Psoriasis.

Authors:  Lara Gibellini; Sara De Biasi; Elena Bianchini; Regina Bartolomeo; Antonella Fabiano; Marco Manfredini; Federica Ferrari; Giuseppe Albertini; Tommaso Trenti; Milena Nasi; Marcello Pinti; Anna Iannone; Carlo Salvarani; Andrea Cossarizza; Giovanni Pellacani
Journal:  PLoS One       Date:  2016-12-09       Impact factor: 3.240

Review 4.  Homocysteine: A Potential Common Route for Cardiovascular Risk and DNA Methylation in Psoriasis.

Authors:  Wen-Ming Wang; Hong-Zhong Jin
Journal:  Chin Med J (Engl)       Date:  2017-08-20       Impact factor: 2.628

5.  Serum inflammatory biomarkers fail to identify early axial spondyloarthritis: results from the SpondyloArthritis Caught Early (SPACE) cohort.

Authors:  Maureen C Turina; Nataliya Yeremenko; Floris van Gaalen; Maikel van Oosterhout; Inger J Berg; Ramona Ramonda; Cristina M C Lebre; Robert Landewé; Dominique Baeten
Journal:  RMD Open       Date:  2017-01-11

6.  Assessment of lipocalin 2, clusterin, soluble tumor necrosis factor receptor-1, interleukin-6, homocysteine, and uric acid levels in patients with psoriasis.

Authors:  Arzu Ataseven; Recep Kesli; Gulcan Saylam Kurtipek; Perihan Ozturk
Journal:  Dis Markers       Date:  2014-04-02       Impact factor: 3.434

7.  Molecular and Cellular Profiling of Scalp Psoriasis Reveals Differences and Similarities Compared to Skin Psoriasis.

Authors:  Juan Ruano; Mayte Suárez-Fariñas; Avner Shemer; Margeaux Oliva; Emma Guttman-Yassky; James G Krueger
Journal:  PLoS One       Date:  2016-02-05       Impact factor: 3.240

8.  Association of Adipokines, Insulin Resistance, Hypertension and Dyslipidemia in Patients with Psoriasis Vulgaris.

Authors:  Melis Coban; Levent Tasli; Sebahat Turgut; Seyma Özkan; Melek Tunç Ata; Fulya Akın
Journal:  Ann Dermatol       Date:  2016-01-28       Impact factor: 1.444

9.  Serum levels of adipokines and cytokines in psoriasis patients: a systematic review and meta-analysis.

Authors:  Fan Bai; Wen Zheng; Yan Dong; Juan Wang; Malgorzata A Garstka; Ruilian Li; Jingang An; Huiqun Ma
Journal:  Oncotarget       Date:  2017-11-01

Review 10.  New insights into different adipokines in linking the pathophysiology of obesity and psoriasis.

Authors:  Yi Kong; Suhan Zhang; Ruifang Wu; Xin Su; Daoquan Peng; Ming Zhao; Yuwen Su
Journal:  Lipids Health Dis       Date:  2019-09-14       Impact factor: 4.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.